Diabetic cardiovascular autonomic neuropathy predicts recurrent cardiovascular diseases in patients with type 2 diabetes

PLoS ONE

Volumn 11, Issue 10, 2016, Pages

  Cha, Seon Ah ^a   Yun, Jae Seung ^a   Lim, Tae Seok ^a   Min, Kyoungil ^a   Song, Ki Ho ^a   Yoo, Ki Dong ^a   Park, Yong Moon ^b   Ahn, Yu Bae ^a   Ko, Seung Hyun ^a  

^a The Catholic University of Korea   (South Korea)

^b NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; HEMOGLOBIN A1C; TRIACYLGLYCEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; ARTICLE; CARDIAC AUTONOMIC NEUROPATHY; CARDIOVASCULAR DISEASE; CARDIOVASCULAR MORTALITY; CARDIOVASCULAR PARAMETERS; CONTROLLED STUDY; DIABETIC CARDIOMYOPATHY; DIABETIC NEPHROPATHY; DISEASE DURATION; EXPIRATION TO INSPIRATION RATIO; FEMALE; HEART RATE VARIABILITY; HEMOGLOBIN BLOOD LEVEL; HIGH RISK PATIENT; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; NON INSULIN DEPENDENT DIABETES MELLITUS; PREDICTIVE VALUE; RECURRENT DISEASE; RISK ASSESSMENT; RISK FACTOR; STANDING; TRIACYLGLYCEROL BLOOD LEVEL; URINARY EXCRETION; VALSALVA MANEUVER; AGED; ALBUMINURIA; BLOOD; BLOOD PRESSURE; CARDIOVASCULAR DISEASES; COMPLICATION; DIABETIC NEUROPATHIES; EXHALATION; FOLLOW UP; HEART RATE; INCIDENCE; PATHOPHYSIOLOGY; PHYSIOLOGY; PROPORTIONAL HAZARDS MODEL;

ADULT; AGED; ALBUMINURIA; BLOOD PRESSURE; CARDIOVASCULAR DISEASES; CHOLESTEROL, LDL; DIABETES MELLITUS, TYPE 2; DIABETIC NEPHROPATHIES; DIABETIC NEUROPATHIES; EXHALATION; FEMALE; FOLLOW-UP STUDIES; HEART RATE; HUMANS; HYPERTENSION; INCIDENCE; MALE; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; RECURRENCE; RISK FACTORS; TRIGLYCERIDES;

EID: 84992364287     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0164807     Document Type: Article

References (42)

1. Adeghate E, Schattner P, Dunn E. An update on the etiology and epidemiology of diabetes mellitus. Annals of the New York Academy of Sciences. 2006; 1084:1-29. Epub 2006/12/08. doi: 10.1196/ annals.1372.029 PMID: 17151290.
2. Korea Centers for Disease Control and Prevention. Korea Health Statistics 2014: Korea National Health and Nutrition Examination Survey (KNHANES VI-2), 2014. Available from http://cdc.go.kr. Accessed 17 Feb 2016
3. Gregg EW, Li Y, Wang J, Burrows NR, Ali MK, Rolka D, et al. Changes in diabetes-related complications in the United States, 1990-2010. The New England journal of medicine. 2014; 370(16):1514-23. Epub 2014/04/18. doi: 10.1056/NEJMoa1310799 PMID: 24738668.
4. Kim CS, Ko SH, Kwon HS, Kim NH, Kim JH, Lim S, et al. Prevalence, awareness, and management of obesity in Korea: data from the Korea national health and nutrition examination survey (1998-2011). Diabetes & metabolism journal. 2014; 38(1):35-43. Epub 2014/03/15. doi: 10.4093/dmj.2014.38.1.35 PMID: 24627826; PubMed Central PMCID: PMCPmc3950193.
5. Ko SH, Kwon HS, Kim DJ, Kim JH, Kim NH, Kim CS, et al. Higher prevalence and awareness, but lower control rate of hypertension in patients with diabetes than general population: the fifth korean national health and nutrition examination survey in 2011. Diabetes & metabolism journal. 2014; 38 (1):51-7. Epub 2014/03/15. doi: 10.4093/dmj.2014.38.1.51 PMID: 24627828; PubMed Central PMCID: PMCPmc3950195.
6. Roh E, Ko SH, Kwon HS, Kim NH, Kim JH, Kim CS, et al. Prevalence and Management of Dyslipidemia in Korea: Korea National Health and Nutrition Examination Survey during 1998 to 2010. Diabetes & metabolism journal. 2013; 37(6):433-49. Epub 2014/01/10. doi: 10.4093/dmj.2013.37.6.433 PMID: 24404515; PubMed Central PMCID: PMCPmc3881328.
7. Korean Diabetes Association. Korean Diabetes Fact Sheet 2015. Available from http://www.diabetes. or.kr/pro. Accessed 01 Feb 2016
8. Korea Statistics. Fact sheet: Causes of Death Statistics 2014. Available from: http://kostat.go.kr. Accessed 10 Feb 2016
9. Gaede P, Vedel P, Larsen N, Jensen GV, Parving HH, Pedersen O. Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes. The New England journal of medicine. 2003; 348 (5):383-93. Epub 2003/01/31. doi: 10.1056/NEJMoa021778 PMID: 12556541.
10. Buse JB, Ginsberg HN, Bakris GL, Clark NG, Costa F, Eckel R, et al. Primary prevention of cardiovascular diseases in people with diabetes mellitus: a scientific statement from the American Heart Association and the American Diabetes Association. Diabetes care. 2007; 30(1):162-72. Epub 2006/12/29. doi: 10.2337/dc07-9917 PMID: 17192355.
11. Leiter LA, Berard L, Bowering CK, Cheng AY, Dawson KG, Ekoe JM, et al. Type 2 diabetes mellitus management in Canada: is it improving? Canadian journal of diabetes. 2013; 37(2):82-9. Epub 2013/ 09/28. doi: 10.1016/j.jcjd.2013.02.055 PMID: 24070797.
12. Jung JH, Lee JH, Noh JW, Park JE, Kim HS, Yoo JW, et al. Current Status of Management in Type 2 Diabetes Mellitus at General Hospitals in South Korea. Diabetes & metabolism journal. 2015; 39 (4):307-15. Epub 2015/08/25. doi: 10.4093/dmj.2015.39.4.307 PMID: 26301192; PubMed Central PMCID: PMCPmc4543194.
13. Boulton AJ, Vinik AI, Arezzo JC, Bril V, Feldman EL, Freeman R, et al. Diabetic neuropathies: a statement by the American Diabetes Association. Diabetes care. 2005; 28(4):956-62. Epub 2005/03/29. PMID: 15793206.
14. Vinik AI, Maser RE, Mitchell BD, Freeman R. Diabetic autonomic neuropathy. Diabetes care. 2003; 26 (5):1553-79. Epub 2003/04/30. PMID: 12716821.
15. Vinik AI, Ziegler D. Diabetic cardiovascular autonomic neuropathy. Circulation. 2007; 115(3):387-97. doi: 10.1161/CIRCULATIONAHA.106.634949 PMID: 17242296.
16. Wackers FJ, Young LH, Inzucchi SE, Chyun DA, Davey JA, Barrett EJ, et al. Detection of silent myocardial ischemia in asymptomatic diabetic subjects: the DIAD study. Diabetes care. 2004; 27(8):1954-61. Epub 2004/07/28. PMID: 15277423.
17. Chyun DA, Wackers FJ, Inzucchi SE, Jose P, Weiss C, Davey JA, et al. Autonomic dysfunction independently predicts poor cardiovascular outcomes in asymptomatic individuals with type 2 diabetes in the DIAD study. SAGE open medicine. 2015; 3:2050312114568476. Epub 2016/01/16. doi: 10.1177/ 2050312114568476 PMID: 26770763; PubMed Central PMCID: PMCPmc4679226.
18. Callahan A, Amarenco P, Goldstein LB, Sillesen H, Messig M, Samsa GP, et al. Risk of stroke and cardiovascular events after ischemic stroke or transient ischemic attack in patients with type 2 diabetes or metabolic syndrome: secondary analysis of the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) trial. Archives of neurology. 2011; 68(10):1245-51. doi: 10.1001/archneurol. 2011.146 PMID: 21670382.
19. van der Heijden AA, Van't Riet E, Bot SD, Cannegieter SC, Stehouwer CD, Baan CA, et al. Risk of a recurrent cardiovascular event in individuals with type 2 diabetes or intermediate hyperglycemia: the Hoorn Study. Diabetes care. 2013; 36(11):3498-502. doi: 10.2337/dc12-2691 PMID: 23877981; PubMed Central PMCID: PMC3816885.
20. Haffner SM, Lehto S, Ronnemaa T, Pyorala K, Laakso M. Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. The New England journal of medicine. 1998; 339(4):229-34. Epub 1998/07/23. doi: 10.1056/ nejm199807233390404 PMID: 9673301.
21. Yun JS, Ko SH, Ko SH, Song KH, Yoo KD, Yoon KH, et al. Cardiovascular Disease Predicts Severe Hypoglycemia in Patients with Type 2 Diabetes. Diabetes & metabolism journal. 2015; 39(6):498-506. Epub 2015/09/16. doi: 10.4093/dmj.2015.39.6.498 PMID: 26370882; PubMed Central PMCID: PMCPmc4696986.
22. Yun JS, Lim TS, Cha SA, Ahn YB, Song KH, Choi JA, et al. Lipoprotein(a) predicts the development of diabetic retinopathy in people with type 2 diabetes mellitus. Journal of clinical lipidology. 2016; 10 (2):426-33. Epub 2016/04/09. doi: 10.1016/j.jacl.2015.12.030 PMID: 27055974.
23. Honda T, Fujimoto K, Miyao Y, Koga H, Ishii M. Current cigarette smoking is an independent risk factor for subacute stent thrombosis in acute myocardial infarction patients. Journal of cardiology. 2014; 63 (5):358-64. Epub 2013/11/19. doi: 10.1016/j.jjcc.2013.10.007 PMID: 24239276.
24. Agarwal DP. Cardioprotective effects of light-moderate consumption of alcohol: a review of putative mechanisms. Alcohol and alcoholism (Oxford, Oxfordshire). 2002; 37(5):409-15. Epub 2002/09/10. PMID: 12217928.
25. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Annals of internal medicine. 1999; 130(6):461-70. Epub 1999/03/13. PMID: 10075613.
26. Consensus development conference on the diagnosis and management of nephropathy in patients with diabetes mellitus. American Diabetes Association and the National Kidney Foundation. Diabetes care. 1994; 17(11):1357-61. Epub 1994/11/01. PMID: 7821182.
27. Ko SH, Song KH, Park SA, Kim SR, Cha BY, Son HY, et al. Cardiovascular autonomic dysfunction predicts acute ischaemic stroke in patients with Type 2 diabetes mellitus: a 7-year follow-up study. Diabetic medicine: a journal of the British Diabetic Association. 2008; 25(10):1171-7. doi: 10.1111/j.1464- 5491.2008.02567.x PMID: 19046195.
28. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England). 1998; 352(9131):837-53. Epub 1998/09/22. PMID: 9742976.
29. Giorda CB, Avogaro A, Maggini M, Lombardo F, Mannucci E, Turco S, et al. Recurrence of cardiovascular events in patients with type 2 diabetes: epidemiology and risk factors. Diabetes care. 2008; 31 (11):2154-9. doi: 10.2337/dc08-1013 PMID: 18782902; PubMed Central PMCID: PMC2571066.
30. Thygesen K, Alpert JS, Jaffe AS, Simoons ML, Chaitman BR, White HD, et al. Third universal definition of myocardial infarction. Circulation. 2012; 126(16):2020-35. Epub 2012/08/28. doi: 10.1161/CIR. 0b013e31826e1058 PMID: 22923432.
31. Sacco RL, Kasner SE, Broderick JP, Caplan LR, Connors JJ, Culebras A, et al. An updated definition of stroke for the 21st century: a statement for healthcare professionals from the American Heart Association/ American Stroke Association. Stroke; a journal of cerebral circulation. 2013; 44(7):2064-89. Epub 2013/05/09. doi: 10.1161/STR.0b013e318296aeca PMID: 23652265.
32. Orchard TJCELL, Maser RE, Kuller LH. Why does diabetic autonomic neuropathy predict IDDM mortality? An analysis from the Pittsburgh Epidemiology of Diabetes Complications Study. Diabetes research and clinical practice. 1996; 34 Suppl:S165-71. Epub 1996/10/01. PMID: 9015687.
33. Ziegler D, Gries FA, Muhlen H, Rathmann W, Spuler M, Lessmann F. Prevalence and clinical correlates of cardiovascular autonomic and peripheral diabetic neuropathy in patients attending diabetes centers. The Diacan Multicenter Study Group. Diabete & metabolisme. 1993; 19(1 Pt 2):143-51. Epub 1993/01/01. PMID: 8314418.
34. Ewing DJ, Clarke BF. Diabetic autonomic neuropathy: present insights and future prospects. Diabetes care. 1986; 9(6):648-65. Epub 1986/11/01. PMID: 3100258.
35. Maser RE, Mitchell BD, Vinik AI, Freeman R. The association between cardiovascular autonomic neuropathy and mortality in individuals with diabetes: a meta-analysis. Diabetes care. 2003; 26(6):1895-901. Epub 2003/05/27. PMID: 12766130.
36. Pop-Busui R, Evans GW, Gerstein HC, Fonseca V, Fleg JL, Hoogwerf BJ, et al. Effects of cardiac autonomic dysfunction on mortality risk in the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial. Diabetes care. 2010; 33(7):1578-84. Epub 2010/03/11. doi: 10.2337/dc10-0125 PMID: 20215456; PubMed Central PMCID: PMCPmc2890362.
37. Valensi P, Sachs RN, Harfouche B, Lormeau B, Paries J, Cosson E, et al. Predictive value of cardiac autonomic neuropathy in diabetic patients with or without silent myocardial ischemia. Diabetes care. 2001; 24(2):339-43. Epub 2001/02/24. PMID: 11213889.
38. Toyry JP, Niskanen LK, Lansimies EA, Partanen KP, Uusitupa MI. Autonomic neuropathy predicts the development of stroke in patients with non-insulin-dependent diabetes mellitus. Stroke; a journal of cerebral circulation. 1996; 27(8):1316-8. Epub 1996/08/01. PMID: 8711794.
39. Vincent JL. Understanding cardiac output. Critical care. 2008; 12(4):174. doi: 10.1186/cc6975 PMID: 18771592; PubMed Central PMCID: PMC2575587.
40. Ahmed AH, Shankar K, Eftekhari H, Munir M, Robertson J, Brewer A, et al. Silent myocardial ischemia: Current perspectives and future directions. Experimental and clinical cardiology. 2007; 12(4):189-96. Epub 2008/07/25. PMID: 18651003; PubMed Central PMCID: PMCPmc2359606.
41. Cohen JA, Estacio RO, Lundgren RA, Esler AL, Schrier RW. Diabetic autonomic neuropathy is associated with an increased incidence of strokes. Autonomic neuroscience: basic & clinical. 2003; 108(1- 2):73-8. doi: 10.1016/j.autneu.2003.07.001 PMID: 14614967.
42. Stone NJ, Robinson JG, Lichtenstein AH, Bairey Merz CN, Blum CB, Eckel RH, et al. 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation. 2014; 129(25 Suppl 2):S1-45. Epub 2013/11/14. doi: 10.1161/01.cir. 0000437738.63853.7a PMID: 24222016.